Home / Health / Tiny Patient, Big Fight: Eye Cancer Retreats
Tiny Patient, Big Fight: Eye Cancer Retreats
2 Nov
Summary
- An eight-month-old infant successfully underwent specialized eye cancer treatment.
- Intra-arterial chemotherapy targeted the rare retinoblastoma, preserving the eye.
- The child is recovering well, showing an encouraging response to treatment.
In a significant medical advancement, Father Muller Medical College Hospital in Mangaluru performed Intra-Arterial Chemotherapy (IAC) on an eight-month-old infant diagnosed with retinoblastoma. This rare form of eye cancer, affecting young children, was treated in the second week of October. The procedure offers a minimally invasive alternative to eye removal.
The IAC procedure involved guiding a thin tube through blood vessels to deliver chemotherapy directly to the tumor. This targeted approach minimizes systemic side effects. The infant's treatment also included intravitreal chemotherapy for residual tumor cells.
The child's journey began with systemic chemotherapy, with one eye already treated by an ophthalmologist. However, the other eye required specialized IAC. The infant is now recovering well, demonstrating an encouraging response to the combined treatment modalities.
